LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk Reduction: Exploring the Evidence With Non-Statin Therapy

June 17, 2018

n this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.

CME 2.00 Credits

Demystifying Narcolepsy in Children: Pathways to Successful Outcomes

November 15, 2017

In this symposium, experts will address best practices in the diagnosis and treatment of narcolepsy, and explore hypersomnia mimics of narcolepsy in children.

CME 2.00 Credits

Management of Narcolepsy and excessive Daytime Sleepines in Obstructive Sleep Apnea

August 09, 2017

In this program, sleep experts including Richard Bogan, MD (Chair), and Suresh Kotagal, MBBS provide valuable insights and best practices for diagnosing and treating narcolepsy in children and adults. Case Studies and in depth participation by Atul Malhotra, MD, Patrick Strollo Jr., MD, and Lisa Collins, RRT, RPSGT, RCP

CME 2.00 Credits

LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: EMERGING INSIGHTS

April 08, 2017

In this program, Dr. Lynn Braun and Dr. Michael Miller present lectures and case studies addressing the management of atherosclerotic cardiovascular disease along with best practices and treatment options.

No Credit Available

The Perfect Storm of Heart Failure and Diabetes: Insights into Pathophysiology and Evidence-Based Treatment Strategies

November 08, 2016

In this educational initiative, experts will address the needs of cardiologists for 1) a grasp of the relationship between DM and HF and the pathophysiology of HF in DM, 2) an explanation of clinical evidence for HF drugs in patients with DM, and 3) an assessment of the profiles of traditional and newer antidiabetic agents in patients with/at risk for cardiovascular disease and interpretation of heart failure-related outcomes.

No Credit Available

Best Practices for Managing Narcolepsy and Obstructive Sleep Apnea: Evidence-Based Strategies and Solutions

June 13, 2016

Thomas Scammell, MD (Chair), Richard Bogan, MD, Michael Thorpy, MD, and Phyllis Zee, MD, PhD address the challenges in the diagnosis of narcolepsy, identify best practices, and assess current and emerging strategies for treatment of EDS in OSA.

No Credit Available

Improving the Care of Patients with Narcolepsy: Evidence-Based Strategies

June 07, 2015

Michael J. Sateia, MD and Helene A Emsellem, MD and Shalanda L. Mitchell, RPSGT, RST describe best practices in recognition, diagnosis and treatment of narcolepsy.

No Credit Available

Optimizing Management of Recurrent Angina after PCI

May 08, 2015

Deepak Bhatt, MD, MPH, FSCAI (Chair); Duane Pinto, MD, FSCAI and Peter Stone, MD, MPH conduct a state-of-the-art discussion and case study on recurrent angina after PCI

No Credit Available

Demystifying Hypertriglyceridemia: Taking a Closer Look at Pathophysiology, Etiology, and Treatment

April 29, 2015

Eliot Brinton, MD and Terry Jacobson, MD discuss the pathophysiology, etiology, and treatment of hypertriglyceridemia.

No Credit Available

The Dynamics of In-Hospital and Post-Discharge ACS Management with Oral Antiplatelet Therapies

March 14, 2015

Jeffrey Anderson, MD, Van de Werf,MD and Marc Sabatine MD, discuss timing/location, dosing, duration of oral antiplatelet therapies, clinical trials, and guidelines.

No Credit Available

Stable Ischemic Heart Disease Management: Challenges and Controversies

November 17, 2014

Valentin Fuster, MD, PhD (Co-Chair), Peter Stone, MD (Co-Chair) lead discussion of best practices and controversies in SIHD

No Credit Available